CLINICAL TRIALS AND MARKET RESEARCH

Similar documents
Volunteering for Clinical Trials

Learning about Clinical Trials

CLINICAL TRIALS: WHAT YOU NEED TO KNOW

Clinical trials patient-education brochure

The Importance of Participating in Clinical Trials in Alzheimer s Disease. Amanda G. Smith, M.D. Medical Director USF Health Byrd Alzheimer Institute

Brain Tumour Australia Information FACT SHEET 22 Clinical Trials: Questions and Answers

FACTS YOU NEED TO KNOW UNITED STATES OF AMERICA

Patient Handbook on Stem Cell Therapies

You ve Got the POWER! What You Should Know About Clinical Trials

FREQUENTLY ASKED QUESTIONS

About Clinical Trials: What They Can Mean For You?

About Clinical Trials

Understanding clinical research trials

Information and resources for African Americans living with multiple myeloma and their caregivers

Access to Unapproved Drugs: Expanded Access and Right to Try

Clinical Trials: What You Need to Know

To document the review procedures for a submission regarding compassionate/treatment use of investigational drugs, biologics and devices.

Medical Research: Participation Issues

Office for Human Subject Protection. University of Rochester

A GUIDE TO THIS REFLECTIONS B RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE

Investigational New Drug Development Steps for CRCs

Clinical trial applications in the EU and US

Compassionate Use: The Ethics and Logistics of Using Investigational Medical Products outside of Clinical Trials

Customer Service Strategies That Will. from the Competition. Louis Feuer, MA, MSW

10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout.

Celldex Compassionate Use Policy

The Big Picture of FTD Research: Funding, Collaboration and the Scoop on Participation

Clinical trial information leaflet and consent

A Patient/Advocate Perspective

THE FDA, THE DRUG APPROVAL PROCESS, AND THE PATIENT VOICE

Clinical Trials: Registration, Results Reporting, and Data Sharing

Functional Classification of Medicine

ROLE OF THE RESEARCH COORDINATOR Investigational New Drug Application-Sponsor Responsibilities 21CFR Part , subpart D

NDIS Goal Setting Support

Clinical Trials A Closer Look

Clinical trials for brain tumours

GUIDELINES FOR CONDUCTING CLINICAL TRIALS.

Fast track Approval process- Ethical considerations

Background: ClincalTrials.gov and the database for Aggregate Analysis of ClincalTrials.gov (AACT)

Research Data Sharing and Security: The Challenges We Face. Jon Mark Hirshon, MD, PhD, MPH Senior Vice-Chair Institutional Review Board

Florida State University Policy 7-IRB-

ROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016

Policy Appendix IV: DRCR.net Industry Collaboration Policies Version 5.0, February 2, 2009

MEDICAL RESEARCH: A CONSUMER S GUIDE FOR PARTICIPATION

Niemann Pick Disease Clinical Trials

Policy Appendix IV: DRCR.net Industry Collaboration Policies Version 6.0, August 2, 2017

ClinicalTrials.gov Updates. Gabrielle Gaspard Assistant Director Human Research Compliance

Current Issues Regarding Data and Safety Monitoring Committees in Clinical Trials

Annual Research Administrators Symposium IRB Compliance. Thursday, July 31, 2014

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS

Talking with Consumers

Three simple steps to a prospect management system

Acceptance of Foreign Clinical Data A U.S. Perspective

Becoming Aware of the Requirements Surrounding Clinical Trial Disclosure (ClinicalTrials.gov)

Toxicology - Problem Drill 24: Toxicology Studies in Pharmaceutical Development

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015

Good Clinical Practice (GCP) & Clinical Trial Registries

Participant Copy. No. Participation is voluntary. Your decision will not affect your health care at Mayo Clinic in any way.

The Right Prescription for Working with Investigational Drug Service at BMC

Good Clinical Practice, GCP. Clinical Trials 101 GCIG CCRN QA

Expanded Access and the Individual Patient IND

Achieving More with the Career Framework

New Drug Application (NDA) Webinar December 6, 2016

Clinical Trials and the Food and Drug Administration

First Place Essay. Katie P.

Pennsylvania Office of Developmental Programs Bureau of Autism Services Pathways to Employment Tool

ICH/GCP Guidelines Self-Evaluation Questionnaire

Insights into the Rare Disease Drug Approval Landscape: Trends and Current Development

Classroom Discussion Guide on Ethics and Public Health Emergencies

COVERAGE ELIGIBILITY OF SERVICES ASSOCIATED WITH A CLINICAL TRIAL

Natural Health Products Directorate (NHPD) Clinical Trial Application and Attestation for Instructions with Sunnybrook specifics

The expectations of my role are clear to me

Getting the Most out of Vocational Rehabilitation

Presentation By Shelly Brunson Matthew Schratwieser Vernon Tilly Jr.

Unpacking Expanded Access to Investigational Drugs and Biologics

Orphan Medicinal Products

Requirements for Humanitarian Use Device (HUD)

GRE A T WITTH A GRE A T WORK ENVIRONMENT.

Talking to Active Investigators: Interview Findings

Roles, Responsibilities, and Communication

Recruitment of Research Participants

Regulatory Issues and Strategies: U.S. FDA

SUBJECT: Public Meeting on Expansion of the Clinical Trial Registry and Results Data Bank [Docket No. NIH ]

How to hire a team of A-players

A LOOK AT WHAT S INSIDE

Streamlining IRB Procedures for Expanded Access

Employment rights 1: Being/becoming employed

2.0 DETERMINING ACTIVITIES THAT QUALIFY as HUMAN RESEARCH or CLINICAL INVESTIGATIONS

A SHORT GUIDE TO THE PROCEDURE FOR A CLINICAL TRIAL APPLICATION IN THE KINGDOM OF BAHRAIN

UT SOUTHWESTERN MEDICAL CENTER AT DALLAS INSTITUTIONAL REVIEW BOARD. Emergency Use of an Investigational Drug, Biologic or Device

Investigational New Drug Application

External IRB Review What Does it Mean for Your Institution

Corporate Medical Policy

I. Purpose. II. Definitions. Last Approval Date

Is your CMO s role evolving fast enough?

Sources of Bias in Metaanalysis

Hi, I'm Derek Baker, the Executive Editor of the ibm.com home. page, and I'm here today to talk with Dan Pelino, who Is IBM's General Manager for

What s New in GCP? FDA Draft Guidance Details FIH Multiple Cohort Trials

Pharmaceutical companies are turning to private practices to conduct clinical trials. An insider tells you what you need to know and what to avoid in

Introduction to NIH OBA and the History of Recombinant DNA Oversight

Transcription:

CLINICAL TRIALS AND MARKET RESEARCH

AAKP's role in Clinical Trials and Market Research AAKP supports innovation in the kidney space. We are actively involved in market research - to share the patient voice and experience with renal companies and clinical trials - to create more and better treatment options for kidney patients, so they can achieve their aspirations. You may have heard the term clinical trials but wonder what that means. Is a clinical trial something you can participate in? What do you need to do to get started? We have pulled together some information that you might find helpful as you decide whether you would like to participate in a clinical trial. What is a clinical trial? A clinical trial is a type of research study that looks at new ways to prevent, detect, or treat disease. A clinical trial is the last phase of research, and looks at the safety and effectiveness of a medicine, medical device, or treatment option. The drug or device needs approval from the Food & Drug Administration (FDA) before being made available to the public. Most clinical trials in the U.S. are approved and monitored by an Institutional Review Board (IRB), an independent committee (meaning the individuals are not directly associated with the trial). The IRB works to ensure clinical trials are ethical and that participants rights and safety are protected. Groundbreaking advancements in medicine are possible with the participation of volunteers in clinical research. How can I get involved? What are the current opportunities to participate in clinical trials? Visit https://aakp.org/clinical-trials/

What are some possible risks of participating in a clinical trial? You may have more health visits than you normally would with your regular doctor The study or medicine may not make you feel better Unpleasant, serious, or life-threatening side effects You may have to spend more money than usual for traveling to visits, the medications, and testing, that is not covered by insurance Improve the way doctors, nurses and other health professionals are trained Influence health laws and funding for health services What are some potential benefits of participating in a clinical trial? Help others who have your disease by contributing to medical research Help doctors and researchers learn more about your disease Learn more about your disease or medical condition Gain access to new research treatments before they are widely available Receive regular and careful medical attention from a research team that includes doctors and other health professionals In some cases, you may be paid for your participation.

What are the different Phases of Clinical Trials? The Food and Drug Administration (FDA) describes five phases of a clinical trial, each having a different purpose and helping to answers different questions. Phase I: Phase II: Researchers test a drug or treatment in a small group of people for the first time. The purpose is to study the drug or treatment to learn about safety and identify side effects. A new drug or treatment is given to a larger group of people to determine its effectiveness and to further study its safety. Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance, called a placebo, or a different drug. Safety continues to be evaluated, and short-term adverse events are studied. Phase III: A new drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it with standard or similar treatments, and collect information that will allow the new drug or treatment to be used safely. Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase IV: Studies occurring after a drug is approved by the FDA and made available to the public (available on the market). Researchers track its safety in the general population, seeking more information about a drug or treatment s benefits, and optimal use. Remember, choosing to participate in a clinical trial is YOUR DECISION. You should never feel pressured to participate, and if you are uncomfortable continuing, you can stop at any time.

What questions should I ask if I am thinking about participating in a clinical trial? What is the purpose of the study? Why do researchers think this will be effective? What are possible short-term and long-term benefits? What are possible short-term and long-term risks and side effects? How are the study results and safety of the participants monitored? How long will the study last? What will my responsibilities be if I participate? Will I have to pay for any part of the trial such as tests, the study drug? What is my health insurance likely to cover? Is transportation, or financial assistance with transportation, for appointments provided? What kinds of therapies, procedures, tests, etc. will I have during the trial? Will I be able to take my regular medications while taking part in the clinical trial? Who will be in charge of my care, and where will I go? How would participating in this study affect my daily life? Can I talk to other people in the study? How is my safety protected? Can I speak to someone who has participated in a clinical trial? Clinical trial participants typically can t share specific information about the trial they are involved in, but they can share about the process, how they decided it was a good fit for them, etc. What happens after a clinical trial is completed? After a clinical trial is completed, the researchers examine the information collected during the study. They will make decisions about the meaning of the study results and determine whether further testing is needed. Results are often published in peer-reviewed scientific journals, where experts review the report before it is published.

Where can I go for additional information? NIH Clinical Trials and You web site: https://www.nih.gov/health-information/nih-clinicalresearch-trials-you/basics ClinicalTrials.gov glossary of common terms: https://www.clinicaltrials.gov/ct2/aboutstudies/glossary